PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Helping insurance companies tackle fraudulent claims by using a combination of blockchain and artificial intelligence. BlockClaim aims to reduce the time spent by car insurers processing false claims, by performing data calculations on a driver and their driving behaviour. This information is fed into the BlockClaim system, which produces a fraud probability risk score.
BlockClaim's technology has been piloted by large insurance firms such as Admiral and Generali. The company's tool consists of a plug-and-play module that is integrated into existing systems used by insurance firms. Revenue is generated via a fixed fee per claim processed via BlockClaim’s product, as well as an initial set-up fee.
days to go:
Expired
investment:
£400,011
Moody is a health-tracking application that connects users with customised health, food and fitness advice based on their moods, symptoms and cycles. It endeavours to become a sustainable force for good in women's health. The company argues that women control >80% of household health spend and are 80% more likely than men to use a digital health app. It aims to harness these trends and capitalise on the global remote health care market that is forecast to hit £40 billion by 2025. 'The Moody Month' app featured in publications like Vogue, Grazia and The Guardian. It has witnessed over 136,000 downloads since its Version 1 release in 2019. The app has compiled over 5 million moods to date. The company will use the investment to scale its business globally and reach 1 million subscribers within a four-year time frame.
days to go:
Expired
investment:
£142,026
Please watch the video for more information
days to go:
Expired
investment:
£964,550
Clim8 is a sustainable investment company which allows people to invest into clean energy and green companies According to the United Nations, the world needs to invest $2.4 trillion dollars, every year, into clean energy, from now until 2035, to meet the climate change targets. Clim8 aims to capitalise on this objective by building a simple way to invest in a targeted portfolio of publicly listed companies that are making an impact in sectors such as clean energy, clean technology, sustainable food, smart mobility, and recycling. The company has successfully raised a seed round of £650,000 in 2019 from investors with backgrounds in finance, including ex Morgan Stanley and Deutsche Bank executives. With the investment, the company plans to launch its proprietary app, invest in recruiting human resources and promote marketing activities to broaden the brand identity.
days to go:
Expired
investment:
£1,523,120
StepJockey are aiming to create healthier, more active buildings by labeling the stairs of the world for calorie burn. StepJockey are encouraging people to take the stairs as opposed to the elevator.
days to go:
Expired
investment:
£280,370
Kwikpay is the first app in the UK to make it easy to top up your prepaid mobiles and prepaid services. Kwikpay have relationships with all major UK mobile operators, as well as mobile operators for another 100 countries.
days to go:
Expired
investment:
£168,821
